Last updated: 2026-09-16 13:20:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
RxSight, Inc. (RXST) operates in the OPHTHALMIC GOODS sector and is listed on NASDAQ. The stock is currently priced at $5,60, with a market capitalisation of $253,93M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,48 to $13,22. This page covers its latest market performance, valuation, price trends and company information.
$253,93M | |
$5,60 | |
$66,54 | |
$4,48 | |
$5,62 | |
8,00 | |
1,09M | |
-- | |
$13,22 | |
$4,48 | |
-- | |
-- |
RxSight, Inc. (RXST) is trading at $5,60 in pre-market trading as of 2026-09-16 12:54:00, down 0,44% ($0,03) from the previous close of $5,62
Pre-market trading shows how investors are pricing RXST before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, RxSight, Inc. (RXST) moved from $6,38 to $5,60, representing a decline of 12,24% ($0,78).
The stock traded between $5,60 and $6,66 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 704,52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 12,8%
RXST is currently trading at $5,60, placing it 12,8% of the way from its 52-week low of $4,48 to its 52-week high of $13,22. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
| Industry | OPHTHALMIC GOODS |
| Employees | 461 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of RxSight, Inc. (RXST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.